Clark Estates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.3M Buy
+265,000
New +$17.9M 4.03% 6
2025
Q2
– Sell
-30,000
Closed -$2.42M – 103
2025
Q1
$2.42M Sell
30,000
-85,000
-74% -$7.31M 0.51% 29
2024
Q4
$8.99M Hold
115,000
– – 1.74% 14
2024
Q3
$10.8M Sell
115,000
-75,123
-40% -$6.31M 2.01% 11
2024
Q2
$14.8M Sell
190,123
-34,877
-16% -$2.84M 2.78% 11
2024
Q1
$20.5M Sell
225,000
-100,000
-31% -$8.32M 3.37% 8
2023
Q4
$25.1M Hold
325,000
– – 4.26% 3
2023
Q3
$22.1M Buy
325,000
+45,000
+16% +$3.27M 4.02% 5
2023
Q2
$22.7M Buy
280,000
+4,000
+1% +$319K 3.83% 8
2023
Q1
$22.6M Buy
276,000
+181,000
+191% +$12.9M 4.49% 5
2022
Q4
$5.55M Buy
+95,000
New +$5.47M 1.15% 18

Other funds holding GEHC

Clark Estates's GEHC Position: Q3 2026 in Review

Clark Estates opened a new position in GE HealthCare (GEHC) in Q3 2026: 265,000 shares worth $17.3M. The stake represents 4.03% of the portfolio and ranks #6 among its holdings. This is a return to the name: Clark Estates previously reported a position in GEHC as recently as Q1 2025.

Clark Estates first reported a position in GEHC in Q4 2022 and has held it in 11 quarters since. The position peaked at $25.1M in Q4 2023. 1,046 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Clark Estates held 265,000 shares of GE HealthCare worth $17.3M as of Q3 2026.
  • GE HealthCare was a new Clark Estates position in Q3 2026.
  • GE HealthCare made up 4.03% of Clark Estates's portfolio in Q3 2026, its #6 holding.
  • Clark Estates first reported a position in GE HealthCare in Q4 2022 and has held it in 11 quarters since.
  • Clark Estates's GE HealthCare position peaked at $25.1M in Q4 2023.
  • 1,046 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Clark Estates's 13F filing for Q3 2026, filed 10 Nov 2026.